Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MH Healthcare (formerly known as MH C&C) is a South Korean healthcare company specializing in infection control and sterilization solutions. Founded in 1997, the company established itself as a market leader through its Medilox brand of high-level disinfectants and automated endoscope reprocessors. In 2016, the company was acquired by Stryker Corporation to enhance Stryker's infection prevention portfolio within the Asia-Pacific region. MH Healthcare's products are primarily used in hospitals and clinics to ensure the sterilization of medical instruments and the maintenance of hygienic clinical environments. The company's offerings include a range of chemical disinfectants, automated washing systems, and infection management consulting services. Today, it operates as a key subsidiary of Stryker, focusing on reducing healthcare-associated infections and improving patient safety.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MH C&C.